Advertisement Screening Compound Resynthesis Services from Chemonaut and iThemba Pharmaceuticals - Pharmaceutical Business review

Advertisement

Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about Chemonaut

Screening Compound Resynthesis Services from Chemonaut and iThemba Pharmaceuticals

Chemonaut has implemented a resynthesis inquiry procedure for situations where a structure query results in no matching compounds being available in the database of more than 5 million in-stock compounds. After submitting the inquiry form, the scientists at iThemba will automatically provide you a highly competitive quotation for resynthesis with a fast turn around time.

For more information, please visit www.chemonaut.com and www.ithembapharma.com

Commenting on the collaboration, Chemonaut’s Managing Director, Ron van der Valk, said "The resynthesis service underlines the commitment to our clients by providing them with a practical solution that facilitates rapid follow-up in the hit-to-lead process. The excellent scientists of iThemba have already shown on several occasions that they deliver on their promises, so we are glad to formalise this partnership and promote the resynthesis service on our online compound sourcing portal."
iThemba’s CSO, Chris Edlin, commented "iThemba is excited to be entering into this collaboration with Chemonaut and is committed to providing world class chemical synthesis capacity backed up by our hands-on Scientific Advisory Board"

Quick Contact

Top Products from Chemonaut